Grey Zone Appendicitis: Role of Blood Test Biomarkers to Detect Early Appendicitis and to Decrease the Incidence of Negative Appendectomy
Launched by ZAGAZIG UNIVERSITY · Feb 14, 2020
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
INTRODUCTION Acute appendicitis is a very common surgical emergency worldwide, with a lifetime risk reported to be 7-8%..Accordingly, appendectomy is the most frequently performed operation worldwide.
Many surgical centers attempt to reduce surgical procedures performed during the night, and delaying appendectomy for 12-24 h does not seem to increase complications
Despite thorough research, the diagnosis of acute appendicitis is still difficult and remains the most common problem in clinical surgery.
In addition to clinical examination of the patients with appendicitis, ultrasonography a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: more than 14years of both sexes.
- • Non pregnant female.
- • Patients taking analgesics. .Patients who diagnosed to have grey zone diagnosis of acute appendicitis (Alvarado score 5-6).
- Exclusion Criteria:
- • Alvarado score \>6 or \< 5.
- • Cases of sure acute appendicitis.
- • Documented Liver disease, biliary disease (congenital or acquired), hemolytic diseases and history of alcoholism.
- • 4) Cases revealed other pathology than appendicitis by CT and laparoscopy.
About Zagazig University
Zagazig University, a prominent educational and research institution located in Egypt, plays a pivotal role in advancing medical knowledge and promoting health innovations through its clinical trials. With a commitment to excellence in research, the university leverages its diverse expertise and state-of-the-art facilities to conduct rigorous clinical studies that aim to improve patient care and outcomes. By fostering collaboration among multidisciplinary teams, Zagazig University contributes significantly to the global medical community, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zagazig, Sharkia, Egypt
Patients applied
Trial Officials
tamer A. alnaimy, MD
Principal Investigator
Zagazig University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials